Disclosing genetic risk for Alzheimer's dementia to individuals with mild cognitive impairment

INTRODUCTION: The safety of predicting conversion from mild cognitive impairment (MCI) to Alzheimer's disease (AD) dementia using apolipoprotein E (APOE) genotyping is unknown. METHODS: We randomized 114 individuals with MCI to receive estimates of 3‐year risk of conversion to AD dementia infor...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Alzheimers Dement (N Y)
Main Authors: Christensen, Kurt D., Karlawish, Jason, Roberts, J. Scott, Uhlmann, Wendy R., Harkins, Kristin, Wood, Elisabeth M., Obisesan, Thomas O., Le, Lan Q., Cupples, L. Adrienne, Zoltick, Emilie S., Johnson, Megan S., Bradbury, Margaret K., Waterston, Leo B., Chen, Clara A., Feldman, Sara, Perry, Denise L., Green, Robert C.
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2020
Assuntos:
Research Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7087414/
https://ncbi.nlm.nih.gov/pubmed/32211507
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/trc2.12002
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados